European committee takes a second look at Alzheimer's drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...
Investor's Business Daily on MSN37m
Stock Market Today: Chevron Breaks Out, But Biotechs Struggle As Eli Lilly Looks Like Short-Sale Play (Live Coverage)
Investors continued to see multiple shades of light red as biotechs continued to struggle in the wake of the postelection ...